Relias Healthcare, founded in 2014 and based in the United States, operates within the Hospitals & Physicians Clinics industry, specifically focusing on medical and surgical hospitals. With an employee base of 201 to 500, the company reported a revenue of approximately 11.9 million USD. The limited document corpus includes a published case study that examines euglycemic diabetic ketoacidosis (euDKA), a rare but serious complication associated with diabetes mellitus. This case study highlights the clinical presentation, management, and diagnostic challenges of euDKA, emphasizing the need for increased awareness among healthcare professionals. The document details a specific patient case and discusses the implications of sodium-glucose cotransporter-2 inhibitors in the context of euDKA. Relias Healthcare appears to be engaged in the dissemination of clinical knowledge aimed at improving patient outcomes in emergency settings, particularly concerning diabetes management. The company’s focus on case studies suggests a commitment to enhancing clinical understanding and practices within the healthcare community.